Provectus Biopharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Institutions | 218,621 | 0.0521% |
Individual Insiders | 33,995,611 | 8.1% |
General Public | 385,307,887 | 91.8% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
18,500,000 | €2.5m | 0% | no data | |||
6,649,298 | €881.4k | 0% | no data | |||
3,532,980 | €468.3k | 0% | no data | |||
2,677,243 | €354.9k | 0% | no data | |||
1,213,153 | €160.8k | 0% | no data | |||
1,077,409 | €142.8k | 0% | no data | |||
200,000 | €26.5k | 0% | no data | |||
145,528 | €19.3k | 0% | no data | |||
100,000 | €13.3k | 0% | 0.01% | |||
50,000 | €6.6k | 0% | no data | |||
26,620 | €3.5k | 0% | no data | |||
22,000 | €2.9k | 0% | no data | |||
20,000 | €2.7k | 0% | no data | |||
1 | €0 | 0% | no data |